Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
for Non-Small Cell Lung Cancer
Drug: Ivonescimab
76 locations incl. Phoenix
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT05899608·Phase 3·Recruiting
Georgia has 2,192 paid clinical trials enrolling now across cities including Atlanta, Augusta and Decatur. Search by condition, age, or phase to find compensated research studies accepting participants near you.
Research sites in Georgia include Emory University Hospital and Winship Cancer Institute, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .